Envision Healthcare Co. (NYSE:EVHC) – Equities research analysts at Oppenheimer reduced their Q2 2018 earnings estimates for shares of Envision Healthcare in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn now forecasts that the company will earn $0.72 per share for the quarter, down from their previous forecast of $0.77. Oppenheimer has a “Outperform” rating and a $40.00 price objective on the stock. Oppenheimer also issued estimates for Envision Healthcare’s Q3 2018 earnings at $0.78 EPS, Q4 2018 earnings at $0.94 EPS and FY2018 earnings at $2.96 EPS.

Several other analysts have also issued reports on EVHC. Stephens restated a “hold” rating and set a $34.00 target price on shares of Envision Healthcare in a research report on Wednesday, January 10th. Zacks Investment Research upgraded shares of Envision Healthcare from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 2nd. ValuEngine lowered shares of Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Cantor Fitzgerald reiterated a “hold” rating and issued a $37.00 price target on shares of Envision Healthcare in a research report on Friday, January 5th. Finally, KeyCorp dropped their price target on shares of Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating for the company in a research report on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $40.73.

Shares of Envision Healthcare (NYSE:EVHC) traded down $0.66 during midday trading on Wednesday, reaching $35.06. 1,706,200 shares of the company traded hands, compared to its average volume of 2,539,160. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. The company has a market capitalization of $4,240.00, a price-to-earnings ratio of -23.53, a price-to-earnings-growth ratio of 0.93 and a beta of 0.57. Envision Healthcare has a 12 month low of $23.77 and a 12 month high of $73.00.

Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business’s quarterly revenue was up 142.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.13 earnings per share.

Hedge funds have recently added to or reduced their stakes in the company. Commonwealth Bank of Australia lifted its holdings in shares of Envision Healthcare by 24.3% in the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after buying an additional 410 shares in the last quarter. Palisade Capital Management LLC NJ purchased a new position in shares of Envision Healthcare in the third quarter worth $229,000. Flinton Capital Management LLC lifted its holdings in shares of Envision Healthcare by 18.7% in the second quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after buying an additional 704 shares in the last quarter. D.A. Davidson & CO. raised its stake in Envision Healthcare by 30.0% during the second quarter. D.A. Davidson & CO. now owns 4,589 shares of the company’s stock valued at $287,000 after purchasing an additional 1,059 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in Envision Healthcare by 1.5% during the second quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after purchasing an additional 70 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: “Q2 2018 EPS Estimates for Envision Healthcare Co. (EVHC) Reduced by Analyst” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/17/q2-2018-eps-estimates-for-envision-healthcare-co-evhc-reduced-by-analyst.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.